Flutter auricular 1: 1 tras la administración de vernakalant para cardioversión de fibrilación auricular

Riva-Silva, Marta de; Montero-Cabezas, José M; Salgado-Aranda, Ricardo; López-Gil, María; Fontenla-Cerezuela, Adolfo; Arribas-Ynsaurriaga, Fernando.
Rev. esp. cardiol. (Ed. impr.) ; 65(11): 1062-1064, nov. 2012. ilus
Artículo en Español | IBECS (España) | ID: ibc-106787

Documentos relacionados

  1. Validation of a novel smartphone-based photoplethysmographic method for ambulatory heart rhythm diagnostics: the SMARTBEATS study.
  2. Late recurrence of atrial fibrillation and flutter in patients referred for elective electrical cardioversion.
  3. When the heart remembers.
  4. The Risk of Thromboembolic Complications in Fontan Patients with Atrial Flutter/Fibrillation Treated with Electrical Cardioversion.
  5. In acute atrial flutter, adding pharmacologic before electrical cardioversion did not increase conversion to normal sinus rhythm.
  6. Atrial Flutter in the Neonate: A Case Study.
  7. Successful treatment of neonatal atrial flutter by synchronized cardioversion: case report and literature review.
  8. Increased beat-to-beat variability of cerebral microcirculatory perfusion during atrial fibrillation: a near-infrared spectroscopy study.
  9. WITHDRAWN: Electrical cardioversion for atrial fibrillation and flutter.
  10. Early initiation of anti-relapse antiarrhythmic therapy in patients with atrial fibrillation and flutter after pharmacological cardioversion with refralon.